Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
GeneDx Holdings Corp. - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
WGS
Nasdaq
8071
www.genedx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for GeneDx Holdings Corp.
GeneDx Stock In Focus After CEO Appointment
- Nov 21st, 2026 4:10 am
GeneDx Announces Leadership Transition
- Nov 18th, 2026 6:00 am
GeneDx Holdings (WGS) Says Sequencing Guided Care In More Than 60% Of Patients
- Nov 13th, 2026 3:15 am
Who Is Paying For GeneDx's Cash Burn?
- Nov 12th, 2026 10:44 am
GeneDx to Participate in Upcoming Investor Conferences
- Nov 11th, 2026 2:05 pm
GeneDx (WGS) Stock Looks About Right After Fresh Sales Progress
- Nov 11th, 2026 4:12 am
Is GeneDx Holdings (WGS) Undervalued After Third Quarter 2026 Results?
- Nov 11th, 2026 2:11 am
Why GeneDx Holdings Stock Just Dropped 16.6%
- Nov 10th, 2026 3:06 pm
4 Post-Earnings Losers Drawing Unusual Options Volume
- Nov 10th, 2026 11:35 am
GeneDx Holdings Corp. Q3 2026 Earnings Call Summary
- Nov 10th, 2026 6:30 am
GeneDx Research Demonstrates Medical Actionability of Exome and Genome Sequencing Results in Large Real-World Study of More Than 300,000 Patients
- Nov 10th, 2026 6:30 am
GeneDx (WGS) Q3 2026 Earnings Call Transcript
- Nov 10th, 2026 12:02 am
GeneDx Holdings Corp (WGS) (Q3 2026) Earnings Call Highlights: Revenue Hits $123. ...
- Nov 9th, 2026 10:10 pm
Sema4 Holdings Corp options imply 21.9% move in share price post-earnings
- Nov 9th, 2026 9:20 pm
GeneDx Q3 Earnings Call Highlights
- Nov 9th, 2026 7:14 pm
GeneDx shares tumble on lowered growth targets
- Nov 9th, 2026 3:42 pm
GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates
- Nov 9th, 2026 3:35 pm
GeneDx Reports Third Quarter 2026 Financial Results
- Nov 9th, 2026 2:05 pm
No Cost Exome Testing Could Be A Game Changer For GeneDx (WGS)
- Nov 7th, 2026 3:16 am
Nutex Health Inc. (NUTX) Q3 Earnings and Revenues Beat Estimates
- Nov 5th, 2026 2:20 pm
Scroll